$TXN
Texas Instruments Inc

2016 Q4 Form 10-Q Financial Statement

#000156459016027067 Filed on November 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2016 Q2
Revenue $3.414B $3.675B $3.273B
YoY Change 7.06% 7.17% 1.27%
Cost Of Revenue $1.277B $1.391B $1.266B
YoY Change -2.37% -2.86% -6.29%
Gross Profit $2.137B $2.284B $2.007B
YoY Change 14.52% 14.37% 6.7%
Gross Profit Margin 62.6% 62.15% 61.32%
Selling, General & Admin $405.0M $442.0M $454.0M
YoY Change 5.19% 1.84% -3.4%
% of Gross Profit 18.95% 19.35% 22.62%
Research & Development $340.0M $353.0M $341.0M
YoY Change 16.04% 11.71% 6.56%
% of Gross Profit 15.91% 15.46% 16.99%
Depreciation & Amortization $227.0M $237.0M $242.0M
YoY Change -13.03% -16.84% -16.84%
% of Gross Profit 10.62% 10.38% 12.06%
Operating Expenses $825.0M $875.0M $874.0M
YoY Change 8.7% 5.42% 0.46%
Operating Profit $1.332B $1.408B $1.131B
YoY Change 16.64% 20.96% 11.98%
Interest Expense -$19.00M -$18.00M -$21.00M
YoY Change -13.64% -18.18% -12.5%
% of Operating Profit -1.43% -1.28% -1.86%
Other Income/Expense, Net $184.0M -$9.000M -$8.000M
YoY Change -734.48% -250.0% -366.67%
Pretax Income $1.497B $1.381B $1.102B
YoY Change 31.43% 20.3% 11.43%
Income Tax $450.0M $363.0M $283.0M
% Of Pretax Income 30.06% 26.29% 25.68%
Net Earnings $1.047B $1.018B $819.0M
YoY Change 25.24% 27.57% 17.67%
Net Earnings / Revenue 30.67% 27.7% 25.02%
Basic Earnings Per Share $1.04 $1.00 $0.81
Diluted Earnings Per Share $1.02 $0.98 $0.79
COMMON SHARES
Basic Shares Outstanding 999.5M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.490B $3.137B $2.539B
YoY Change 8.45% 14.7% -23.2%
Cash & Equivalents $1.154B $1.369B $1.235B
Short-Term Investments $2.336B $1.768B $1.304B
Other Short-Term Assets $910.0M $789.0M $926.0M
YoY Change -9.0% -39.4% -35.47%
Inventory $1.790B $1.808B $1.876B
Prepaid Expenses
Receivables $1.267B $1.447B $1.348B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.457B $7.181B $6.689B
YoY Change 5.41% -1.48% -17.01%
LONG-TERM ASSETS
Property, Plant & Equipment $2.512B $2.545B $2.557B
YoY Change -3.24% -3.2% -4.77%
Goodwill $4.362B $4.362B
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $260.0M $233.0M $224.0M
YoY Change 5.69% 7.87% -1.75%
Other Assets $79.00M $82.00M $385.0M
YoY Change 27.42% -10.87% -1.79%
Total Long-Term Assets $8.974B $9.035B $9.004B
YoY Change -1.99% -2.33% -4.94%
TOTAL ASSETS
Total Short-Term Assets $7.457B $7.181B $6.689B
Total Long-Term Assets $8.974B $9.035B $9.004B
Total Assets $16.43B $16.22B $15.69B
YoY Change 1.24% -1.96% -10.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $396.0M $428.0M $416.0M
YoY Change 2.59% 16.62% -0.24%
Accrued Expenses $1.154B $1.040B $880.0M
YoY Change 7.45% -0.57% -2.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $631.0M $634.0M $637.0M
YoY Change -36.9% -36.6% -63.6%
Total Short-Term Liabilities $2.264B $2.170B $1.991B
YoY Change -11.39% -13.2% -37.64%
LONG-TERM LIABILITIES
Long-Term Debt $2.978B $2.977B $2.975B
YoY Change -4.55% -4.95% -5.07%
Other Long-Term Liabilities $554.0M $748.0M $725.0M
YoY Change -3.15% 18.73% 12.4%
Total Long-Term Liabilities $3.532B $2.977B $3.700B
YoY Change 13.21% -4.95% 18.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.264B $2.170B $1.991B
Total Long-Term Liabilities $3.532B $2.977B $3.700B
Total Liabilities $5.958B $5.930B $5.731B
YoY Change -5.19% -9.74% -21.78%
SHAREHOLDERS EQUITY
Retained Earnings $33.11B $32.43B
YoY Change 6.19% 5.54%
Common Stock $3.415B $3.498B
YoY Change 1.34% 5.9%
Preferred Stock
YoY Change
Treasury Stock (at cost) $25.52B $25.10B
YoY Change 6.05% 6.59%
Treasury Stock Shares 744.8M shares $739.7M
Shareholders Equity $10.47B $10.29B $9.962B
YoY Change
Total Liabilities & Shareholders Equity $16.43B $16.22B $15.69B
YoY Change 1.24% -1.96% -10.49%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2016 Q2
OPERATING ACTIVITIES
Net Income $1.047B $1.018B $819.0M
YoY Change 25.24% 27.57% 17.67%
Depreciation, Depletion And Amortization $227.0M $237.0M $242.0M
YoY Change -13.03% -16.84% -16.84%
Cash From Operating Activities $1.387B $1.465B $1.109B
YoY Change -11.03% 3.97% 35.24%
INVESTING ACTIVITIES
Capital Expenditures -$110.0M -$139.0M -$158.0M
YoY Change -32.93% 0.0% 26.4%
Acquisitions
YoY Change
Other Investing Activities -$575.0M -$464.0M $223.0M
YoY Change 12.52% -187.88% -555.1%
Cash From Investing Activities -$685.0M -$603.0M $65.00M
YoY Change 1.48% -255.01% -137.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.000B
YoY Change
Cash From Financing Activities -917.0M -728.0M -1.220B
YoY Change -9.83% -60.63% 73.3%
NET CHANGE
Cash From Operating Activities 1.387B 1.465B 1.109B
Cash From Investing Activities -685.0M -603.0M 65.00M
Cash From Financing Activities -917.0M -728.0M -1.220B
Net Change In Cash -215.0M 134.0M -46.00M
YoY Change 61.65% -362.75% -20.69%
FREE CASH FLOW
Cash From Operating Activities $1.387B $1.465B $1.109B
Capital Expenditures -$110.0M -$139.0M -$158.0M
Free Cash Flow $1.497B $1.604B $1.267B
YoY Change -13.12% 3.62% 34.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
txn Restructuring Charges Other
RestructuringChargesOther
-3000000
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
999485728
dei Document Type
DocumentType
10-Q
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-43000000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-40000000
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-20000000
us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
1000000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-1000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
19000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
927000000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.02
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1036000000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1049000000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.02
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
30000000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2120000000
us-gaap Operating Income Loss
OperatingIncomeLoss
3132000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
68000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3077000000
us-gaap Net Income Loss
NetIncomeLoss
2150000000
us-gaap Depreciation
Depreciation
466000000
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
393000000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2170000000
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1740815939
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
739693480
CY2016Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
201000000
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
35000000
CY2016Q3 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
547000000
CY2016Q3 us-gaap Liabilities
Liabilities
5930000000
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
1741000000
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1757000000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
32432000000
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
25102000000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-542000000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
10286000000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16216000000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14000000
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-160000000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-26000000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
153000000
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
56000000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
24000000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3029000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
421000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
2171000000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2625000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
35000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
499000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
1000000000
us-gaap Payments Of Dividends
PaymentsOfDividends
1147000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1657000000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
484000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2695000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
369000000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1199000000
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
787000000
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12000000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
31000000
CY2015Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
11000000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2119000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13000000
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12000000
us-gaap Restructuring Charges
RestructuringCharges
5000000
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1000000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2169000000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
410000000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1000000000
CY2015Q4 us-gaap Inventory Net
InventoryNet
1691000000
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
2218000000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1165000000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
109000000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
846000000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
736000000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
789000000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
7181000000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4982000000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2437000000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2545000000
CY2016Q3 us-gaap Long Term Investments
LongTermInvestments
233000000
CY2016Q3 us-gaap Goodwill
Goodwill
4362000000
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1344000000
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
355000000
CY2016Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
50000000
CY2016Q3 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
64000000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000000
CY2016Q3 us-gaap Assets
Assets
16216000000
CY2016Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
634000000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
428000000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
647000000
CY2016Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
68000000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2555000000
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2977000000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3120000000
CY2015Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
196000000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
37000000
CY2015Q4 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
376000000
CY2015Q4 us-gaap Liabilities
Liabilities
6284000000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
1741000000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1629000000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31176000000
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24068000000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-532000000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
9946000000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16230000000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7000000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1740815939
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
729547527
us-gaap Depreciation
Depreciation
594000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
240000000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-106000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
241000000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
21000000
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
65000000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
23000000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2838000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
387000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
10000000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1713000000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2455000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-8000000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
373000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
498000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
1000000000
us-gaap Payments Of Dividends
PaymentsOfDividends
1058000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2114000000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
332000000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
129000000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
68000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3277000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-66000000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1133000000
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
957000000
CY2016Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14000000
CY2016Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2941000000
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9. <font style="text-decoration:underline;">Contingencies</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Indemnification guarantees</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. </p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warranty costs/product liabilities</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the&#160;likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Typically, our warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claims may exceed the price of our products.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">General</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&nbsp;</p></div>
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1597000000
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2944000000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1361000000
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Indemnification guarantees</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. </p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warranty costs/product liabilities</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the&#160;likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Typically, our warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claims may exceed the price of our products.</p></div>
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2016Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
11000000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
30000000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2385000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13000000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2016Q3 us-gaap Restructuring Reserve
RestructuringReserve
23000000
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
32000000
us-gaap Payments For Restructuring
PaymentsForRestructuring
10000000
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
4000000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1369000000
us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2904000000
CY2016Q3 txn Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
40000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000000
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000000
CY2016Q3 us-gaap Commercial Paper
CommercialPaper
0
CY2016Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000000
CY2016Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3625000000
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4125000000
CY2016Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
14000000
CY2015Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5000000
CY2016Q3 us-gaap Long Term Debt
LongTermDebt
3611000000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
4120000000

Files In Submission

Name View Source Status
0001564590-16-027067-index-headers.html Edgar Link pending
0001564590-16-027067-index.html Edgar Link pending
0001564590-16-027067.txt Edgar Link pending
0001564590-16-027067-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
txn-10q_20160930.htm Edgar Link pending
txn-20160930.xml Edgar Link completed
txn-20160930.xsd Edgar Link pending
txn-20160930_cal.xml Edgar Link unprocessable
txn-20160930_def.xml Edgar Link unprocessable
txn-20160930_lab.xml Edgar Link unprocessable
txn-20160930_pre.xml Edgar Link unprocessable
txn-ex31a_9.htm Edgar Link pending
txn-ex31b_7.htm Edgar Link pending
txn-ex32a_8.htm Edgar Link pending
txn-ex32b_6.htm Edgar Link pending